March 30 (SeeNews) - Serbian drug maker Galenika may start producing the anti-malarial drug chloroquine to be used in the experimental treatment of the novel coronavirus (COVID-19) as recommended by the Chinese, South Korean and Italian health authorities, President Aleksandar Vucic said.